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Inflammatory bowel diseases (IBDs) like Crohn’s 
disease and ulcerative colitis are thought to re-
sult from a dysregulated response of the intesti-
nal immune system to bacteria present in the 
commensal flora (Strober et al., 2007; Rescigno, 
2008). To date, it remains unclear whether a 
breakdown of immune tolerance is the primary 
cause of these diseases or occurs downstream of 
an initial defect of the intestinal barrier and in-
testinal epithelial cells (IECs; Nenci et al., 2007; 
Strober et al., 2007; Rescigno, 2008).
STAT3 is a transcription factor activated   
by a variety of cytokines and growth factors 
(Chapman  et  al.,  2000;  Levy  and  Darnell, 
2002). Upon activation, STAT3 translocates to 
the nucleus, where it regulates genes involved 
in apoptosis, proliferation, migration, and sur-
vival, depending on the cell type (Akira, 2000). 
STAT3 plays an important role in several auto-
immune diseases as well as IBD, where it is ac-
tivated in various cell types (Lovato et al., 2003; 
Mudter et al., 2005). Strikingly, mice with a 
deletion of STAT3 in hematopoietic cells and 
particularly in macrophages develop spontane-
ous colitis, most likely because of the lack of 
negative regulation of activation (Takeda et al., 
1999; Welte et al., 2003; Alonzi et al., 2004). 
Conversely, mice with a T cell–specific dele-
tion of STAT3 activity are protected from a 
variety of autoimmune disease models, high-
lighting a proinflammatory role of STAT3 in   
T cells (Liu et al., 2008). Thus, there is clear evi-
dence  for  cell  type–dependent  functions  of 
STAT3 in maintaining intestinal immune ho-
meostasis. In support of this assumption, cyto-
kines like IL-6 that are associated with STAT3 
activation are elevated in mucosal biopsies of 
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Signal transducer and activator of transcription (STAT) 3 is a pleiotropic transcription 
factor with important functions in cytokine signaling in a variety of tissues. However, the 
role of STAT3 in the intestinal epithelium is not well understood. We demonstrate that 
development of colonic inflammation is associated with the induction of STAT3 activity in 
intestinal epithelial cells (IECs). Studies in genetically engineered mice showed that epithe-
lial STAT3 activation in dextran sodium sulfate colitis is dependent on interleukin (IL)-22 
rather than IL-6. IL-22 was secreted by colonic CD11c+ cells in response to Toll-like recep-
tor stimulation. Conditional knockout mice with an IEC-specific deletion of STAT3 activity 
were highly susceptible to experimental colitis, indicating that epithelial STAT3 regulates 
gut homeostasis. STAT3IEC-KO mice, upon induction of colitis, showed a striking defect of 
epithelial restitution. Gene chip analysis indicated that STAT3 regulates the cellular stress 
response, apoptosis, and pathways associated with wound healing in IECs. Consistently, both 
IL-22 and epithelial STAT3 were found to be important in wound-healing experiments in 
vivo. In summary, our data suggest that intestinal epithelial STAT3 activation regulates 
immune homeostasis in the gut by promoting IL-22–dependent mucosal wound healing.
© 2009 Pickert et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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vation in experimental colitis, we generated mice with an 
IEC-specific deletion of STAT3 activity (STAT3IEC-KO). 
Accordingly, mice with floxed STAT3 alleles (Takeda et al., 
1998) were crossbred to Villin-Cre mice expressing the 
Cre-recombinase specifically in IECs (Madison et al., 2002). 
Cre-mediated deletion of STAT3 was restricted to the co-
lon and the small intestine of STAT3IEC-KO mice, whereas 
other organs remained unaffected (Fig. 1 C). Immunohisto-
chemistry confirmed the specific absence of STAT3 phos-
phorylation in epithelial cells of STAT3IEC-KO mice (Fig. 1 D). 
STAT3IEC-KO mice developed normally and showed no 
spontaneous gut pathology upon histological analysis (Fig. 1 E 
and Fig. S1). However, IECs of STAT3IEC-KO mice showed 
reduced expression of well-established target genes of the 
STAT3 signaling pathway, such as bclXL and socs3 (Fig. 1 F 
and Fig. S2 A; Levy and Darnell, 2002).
To investigate the functional role of epithelial STAT3 
activation during colitis development, STAT3IEC-KO and con-
trol (STAT3fl) mice were challenged with 2.5% DSS for 7 d 
to induce colitis. All mice developed colitis within 10 d, as 
indicated by the time-dependent weight loss. Strikingly, 
however, although control mice were able to control weight 
loss after removing the DSS at day 7, STAT3IEC-KO mice lost 
significantly more weight after DSS treatment even after the 
IBD patients, and many of these cytokines have been shown 
to play an active role in the regulation of the inflammatory 
process (Atreya et al., 2000; Strober et al., 2007). It is there-
fore tempting to speculate that during the course of the in-
flammatory  process,  IECs  respond  to  cytokines  that  may 
regulate the epithelial barrier via STAT3. In this report, we 
describe by using newly generated IEC-specific STAT3-de-
ficient mice that STAT3 signaling in the intestinal epithelium 
is an important regulator of mucosal wound healing and is 
induced by IL-22 during acute experimental colitis.
RESULTS AnD DISCUSSIOn
Epithelial STAT3 activity regulates intestinal inflammation
To study the regulation of intestinal epithelial STAT3 ac-
tivity, we induced experimental colitis by treatment of mice 
with dextran sodium sulfate (DSS). Although at early time 
points (days 0 and 2) no significant epithelial STAT3 activ-
ity was detectable in the colon, STAT3 activity was present 
around day 5, as demonstrated by phosphorylated STAT3 
(pSTAT3) staining of almost 80% of colonic IECs (Fig. 1 A). 
Colitis-associated  induction  of  epithelial  STAT3  activity 
was confirmed by Western blotting of epithelial cell lysates 
for pSTAT3 in mice with DSS-induced colitis (Fig. 1 B). 
To investigate the functional role of epithelial STAT3 acti-
Figure 1.  Generation and analysis of STAT3IEC-KO mice. (A) pSTAT3 staining of the colon from mice treated with DSS for up to 5 d. pSTAT3-positive IECs 
were counted from a total of 10 crypts at days 0 and 5 and are shown as the percentage of all counted IECs. Data show mean values ± SD and are represen-
tative of three independent experiments. Arrows indicate the epithelial cell layer. ***, P < 0.001. (B) Western blotting for pSTAT3 was performed from IECs iso-
lated from wild-type mice at the indicated time points after DSS treatment. Probing of STAT3 and -actin served as controls. The experiment was performed 
twice with similar results. (C) Presence of the deleted STAT3 allele selectively in the gut of STAT3IEC-KO mice. DNA was isolated from a variety of organs and 
subjected to an allele-specific PCR. (D) Immunohistochemical analysis of pSTAT3 activity in the small intestine. Note the specific lack of pSTAT3 staining in 
IECs of STAT3IEC-KO mice (arrows). (E) H&E staining of paraffin-embedded sections from 12-wk-old control and STAT3IEC-KO mice. (F) Changes in the expression 
levels of the STAT3 target genes bclXL and socs3, as measured by qPCR from IECs isolated from the proximal (DD) and distal (Il.) small intestine and the colon 
(Co.). Data show mean values of three mice per group ± SD relative to HPRT. A second experiment gave similar results. Bars, 100 µm. HPF, high power field.JEM VOL. 206, July 6, 2009  1467
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genome-wide expression analysis of control and STAT3IEC-KO  
epithelial cells of   DSS-treated mice (available from the Gene 
Expression Omnibus under accession no. GSE15955). 52 
out of the 45,000 examined expression tags were more 
than twofold down-regulated and 274 were up-regulated 
in epithelial cells from STAT3IEC-KO mice (Fig. 3 A). By 
gene ontology analysis, we found a significant enrichment 
of apoptosis-related genes in the gene cluster of the most 
up-regulated genes (Fig. 3 B, top). Conversely, a highly 
significant  enrichment  of  genes  associated  with  wound 
healing and the cellular stress response was observed in the 
gene cluster of the most repressed genes (Fig. 3 B, bot-
tom). In an independent set of experiments, quantitative 
PCR  studies  were  performed  using  isolated  IECs  from 
DSS-treated STAT3IEC-KO and control mice. Genes associ-
ated to apoptosis regulation (mcl1 and survivin), prolifera-
tion (myc, Reg3b, and Pla2g5), and wound healing (smo) 
were significantly reduced in STAT3IEC-KO mice (Fig. S2 B). 
In summary, our data suggested that epithelial STAT3 or-
chestrates signaling pathways involved in IEC homeostasis 
and mucosal wound healing.
To investigate whether STAT3 promotes intestinal wound 
healing in the absence of DSS colitis, we performed wound-
healing experiments in vivo. For this purpose, mucosal 
biopsies were taken from the colon of live mice using an   
DSS had been removed (Fig. 2 A). Methylene blue–aided 
endoscopy of the mice at the end of the experiment revealed 
more pronounced tissue damage with severe epithelial ero-
sions, disruption of the normal vessel structure, and bleeding 
in STAT3IEC-KO mice when compared with control mice 
(Fig. 2, B and C; Becker et al., 2005). These findings were 
confirmed by histopathological analysis of colonic cross sec-
tions, in which we found significantly diminished numbers of 
colonic crypts and IECs in STAT3IEC-KO mice compared with 
controls (Figs. 2, D and E). To investigate whether the lack 
of epithelial STAT signaling may influence epithelial turn-
over, we analyzed proliferation and apoptosis in mice treated 
with DSS. Strikingly, STAT3IEC-KO mice showed less prolif-
eration, as indicated by fewer KI-67+ IECs per crypt when 
compared with control animals (Fig. 2 F). In addition, both 
active caspase-3 and Tdt-mediated dUTP-biotin nick-end 
labeling (TUNEL) staining demonstrated a higher number of 
apoptotic IECs in STAT3IEC-KO mice (Fig. 2 G). Thus, in 
summary, our data indicate that epithelial STAT3 protects 
mice from colitis by regulating epithelial cell homeostasis.
STAT3 during acute colitis regulates several pathways 
involved in mucosal wound healing
To identify pathways potentially involved in the regulation 
of  epithelial  cell  homeostasis  by  STAT3,  we  performed 
Figure 2.  Severe colitis with epithelial erosions in STAT3IEC-KO mice. (A) Control (n = 13) and STAT3IEC-KO (n = 9) mice were treated with 2.5% DSS 
for 1 wk, as indicated in Materials and methods. Weight loss was monitored over time and is indicated as the percentage of the initial weight ± SEM. 
The data are representative of four independent experiments. (B) Endoscopic examination of mice at day 15. (C) In vivo staining of the colon with methy-
lene blue to visualize the colonic crypt pattern. (D) Histological analysis showing a severe loss of crypts. Epithelial erosion was scored as indicated in 
Materials and methods. Means of seven animals per group ± SEM of one out of three independent experiments is shown. (E) Representative H&E stain-
ing of the colon. (F) Immunostaining of the proliferation marker Ki-67 using colonic tissue samples of mice treated with DSS for 1 wk. Statistical analy-
sis of Ki-67+ IECs per crypt (n = 8). *, P < 0.05. (G) Histochemical analysis of apoptosis using TUNEL and active caspase-3 staining. Representative 
images of four experiments are shown. Arrows indicate caspase or TUNEL+ epithelium. Bars, 100 µm.1468 EPITHELIAL STAT3 PROMOTES MUCOSAL HEALING | Pickert et al.
sis of the wound bed in wild-type mice 2 d after taking the 
biopsy indicated a localized induction of IEC STAT3 activ-
ity that was clearly confined to crypts adjacent to the wound 
bed (Fig. 3 D). Strikingly, wound-associated STAT3 activity 
colocalized with increased epithelial proliferation, as indi-
cated by the presence of KI-67+ IECs. Thus, our data sup-
port an important function of STAT3 signaling for mucosal 
wound healing.
endoscopy-guided biopsy forceps, resulting in defined wounds 
of 800 µm in size. The healing of these wounds was then 
monitored for several days, and the wound size was com-
pared between control and STAT3IEC-KO mice by endoscop-
ical analysis. Although in wild-type mice the wounds usually 
healed within 6 d, wound healing was significantly delayed 
in STAT3IEC-KO mice and the wounds had still not closed at 
day 6 (Fig. 3 C). Furthermore, immunohistochemical analy-
Figure 3.  Intestinal epithelial STAT3 regulates mucosal wound healing. (A) Gene chip analysis of IECs from two control and two STAT3IEC-KO mice. 
Mice were treated for 5 d with DSS, and IECs were isolated as described in Materials and methods. (B) Affymetrix expression data were analyzed using 
the gene ontology algorithm, as indicated in Materials and methods. The red line indicates P < 0.05. Pathways reaching significance are shown in red.  
(C) In vivo wound-healing assay as described in Materials and methods. Wound healing was compared between control (n = 6) and STAT3IEC-KO (n = 5) 
mice by video endoscopies on days 0, 2, 4, and 6. Data show the mean diameters of the wound bed (double arrows) relative to the diameter of the fresh 
wound (percentage) of four to six wounds ± SD. Representative images of three independent experiments are shown from days 0 and 4. (D) Histochemi-
cal analysis of the wound bed (circle) 2 d after in vivo wounding in wild-type mice. pSTAT3 and KI-67+ cells (arrows) were confined to crypts in close 
proximity to the wound. A second experiment gave similar result. Bars, 100 µm.JEM VOL. 206, July 6, 2009  1469
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DSS treatment showing a lack of pSTAT3 immunoreactivity 
in IECs from IL-22–deficient mice (Fig. 4 B). In agreement 
with previous reports (Zheng et al., 2008), we found that 
both IL-22 receptor chain genes (IL-22R and IL-10R2) were 
strongly expressed in the small and large bowel compared 
with other organs (Fig. S3). To provide evidence for a direct 
effect of IL-22 on IECs, full-thickness colon pieces from 
wild-type mice were cultured in the presence or absence of 
IL-22  and  subsequently  immunostained  for  pSTAT3.  Al-
though untreated colons did not show pSTAT3 immuno-
reactivity within the epithelium, treatment with IL-22 led to 
strong epithelial pSTAT3 staining (Fig. 4 C, top). This find-
ing was further confirmed by Western blotting of primary 
IECs cultured in the presence of IL-22 (Fig. 4 C, bottom). 
Based on our observations, we propose that IL-22, via the 
activation of STAT3, protects the intestinal epithelium and 
promotes mucosal wound healing during acute experimental 
colitis. In support of this model, IL-22/ mice developed 
STAT3 is specifically induced by IL-22 released  
from CD11c+ cells during acute experimental colitis
Depending on the target cells, STAT3 mediates signal trans-
duction of several cytokines and proinflammatory mediators 
like IL-6 and IL-22 (Chapman et al., 2000; Levy and Darnell, 
2002). Interestingly the latter two cytokines are strongly ex-
pressed in human patients with IBDs (Reinecker et al., 1993; 
Brand et al., 2006). Although both cytokines were undetect-
able in colonic biopsies at days 0 and 2 after DSS treatment, 
IL-22 was significantly induced at days 5 and 7, whereas IL-6 
was detected at day 7 only (Fig. 4 A). Next, we compared epi-
thelial STAT3 activity in DSS-treated wild-type, IL-6/, 
and IL-22/ mice. Strikingly, although IL-6–deficient mice 
challenged with DSS for 1 wk showed intestinal epithelial 
STAT3 activation indistinguishable from wild-type mice,   
IL-22/ mice showed an almost complete lack of epithelial 
STAT3 activity (Fig. 4 B). This finding was confirmed by 
Western blotting of IEC lysates from animals after 1 wk of 
Figure 4.  IL-22 directs epithelial STAT3 activity in acute DSS-induced colitis. (A) IL-6 and IL-22 expression (±SD) in the gut of mice treated for  
1 wk with DSS. Biopsies were taken by endoscopy at the indicated time points and analyzed by quantitative PCR. The experiment was performed twice 
with similar results. (B) Wild-type, IL-6/, and IL-22/ mice were treated with DSS for 1 wk. pSTAT3 immunostaining of the colonic epithelium (arrows). 
Representative images of three experiments are shown (n = 5). (bottom right) pSTAT3 Western blot using extracts of isolated IECs from this experiment. 
(C, top) pSTAT3 immunostaining of colon pieces isolated from wild-type mice and cultured in medium for 2 h in the presence or absence of recombinant 
IL-22. Representative images of three experiments with similar results are shown. Arrows indicate the epithelial cell layer. (bottom) pSTAT3 Western blot 
of IL-22–stimulated IECs isolated from control and STAT3IEC-KO mice. STAT3 and -actin probing of the same blot served as a control. (D) LPMCs from 
DSS-treated wild-type mice were isolated as indicated in Materials and methods. Cells were stimulated in medium for 48 h as indicated, and superna-
tants were analyzed for IL-22 by ELISA. The experiment was performed three times with similar results. (E) Immunostaining for CD11c and IL-22 of the 
inflamed colon of wild-type mice treated with DSS for 1 wk. The bottom image is an overlay of the single channels. Arrows indicate colocalization. Rep-
resentative images of three experiments are shown. (F) IL-22 levels in purified lamina propria cells. LPMCs were isolated from five wild-type mice treated 
with DSS for 7 d and stimulated for 24 h as indicated. Supernatants were analyzed by ELISA. Data show cytokine expression of pooled cells from five 
mice of one experiment out of three. (inset) Colocalization of CD11c and IL-22 using immunostaining. (G) CD11c+ cells were isolated from the lamina 
propria of three wild-type mice and were stimulated as indicated. IL-22 was analyzed by ELISA from supernatants collected 24 h later. The experiment 
shows mean values ± SD and was performed twice with similar results. Bars: (B, C, and E) 100 µm; (F) 10 µm. n.d., not detectable.1470 EPITHELIAL STAT3 PROMOTES MUCOSAL HEALING | Pickert et al.
was described as an innate source of IL-22 in human and 
mouse lymphoid tissue (Cella et al., 2009). In this report, we 
confirm that IL-22 during acute colitis is produced by cells of 
the innate immune system, as well as by CD4+ T cells. How-
ever, CD4+ T cells are present only in small numbers in the 
lamina propria during the initial acute phase of DSS-induced 
colitis and are largely confined to lymphoid follicles (unpub-
lished data). In contrast, CD11c+ DCs are present in sig-
nificant numbers in the colon of healthy animals and are 
strategically located directly underneath the surface epithe-
lium (Rimoldi et al., 2005). Thus, activation of these DCs via 
TLRs either by invading pathogens or by transepithelial sam-
pling of bacteria may promote rapid activation of the IL-22–
STAT3 axis at the intestinal epithelium. Our model is in 
keeping with a recent study showing that Myd88-mediated 
signaling through mesenchymal cells is required for the am-
plification of mouse colonic epithelial progenitors that occurs 
in response to DSS-induced injury (Pull et al., 2005). How-
ever, our data do not exclude that in chronic colitis or at later 
stages of established colitis, IL-22 may also be significantly 
expressed by other inflammatory cells infiltrating the lamina 
propria, such as Th17 cells, or that other factors may be ex-
pressed that may also stimulate IEC STAT3 activity. Among 
those lines, NK cells have recently been established as pro-
ducers of IL-22 and some NK cell populations express CD11c 
(Zenewicz et al., 2008). Although our data confirm that cells 
expressing the NK cell marker DX5 can produce IL-22, little 
IL-22 was found in supernatants of DX5+ cells isolated from 
the lamina propria of mice treated with DSS (Fig. S7).
Our model is in agreement with previous reports suggest-
ing that IL-22 is a central regulator of tissues in inflammatory 
conditions, and several studies have previously suggested a 
protective role for IL-22 in the regulation of gut inflamma-
tion. Accordingly, IL-22 gene delivery was shown to amelio-
rate DSS-induced colitis (Sugimoto et al., 2008). In another 
study, in a model of experimental Citrobacter rodentium infec-
tion, IL-22/ mice showed increased intestinal epithelial 
damage, along with systemic bacterial burden and signifi-
cantly increased mortality, when compared with control 
mice (Zheng et al., 2008). In this study, IL-22 induced the 
expression of Reg proteins, which are released by IECs and 
exert antimicrobial functions. This observation is in keeping 
with our present observation that STAT3IEC-KO mice showed 
greatly diminished expression of RegIII and RegIII in gene 
chip experiments (Fig. 3), suggesting that STAT3 functions 
as a key regulator for the expression of these genes. IL-22–in-
duced STAT3 activation in the injured gut may therefore not 
only promote IEC proliferation and protection against apopto-
sis but may also serve to control bacterial growth in the lamina 
propria adjacent to the wound. Our data are also consistent 
with two very recently published studies in which IL-6/gp130-
mediated STAT3 activation during tumor development was 
shown to drive cell proliferation of enterocytes (Bollrath   
et al., 2009; Grivennikov et al., 2009). In conclusion, IL-22/
STAT3 signaling in IECs emerges as an important protective 
pathway for the mucosal immune system. STAT3 seems   
more severe colitis than wild-type mice, and showed a loss of 
mucosal architecture and a lack of IECs comparable to that 
seen in STAT3IEC-KO mice (Fig. S4). Moreover, IL-22/ 
mice showed delayed intestinal wound healing when com-
pared with wild-type mice (Fig. S5). Similarly, DSS-induced 
colitis in wild-type mice that were treated with a neutraliz-
ing antibody against IL-22 was more severe than in control-
treated animals (unpublished data). Therefore, our data suggest 
that IL-22 is an important regulator of mucosal wound heal-
ing via STAT3 activation in IECs.
To investigate the source of IL-22 in DSS-induced colitis, 
we first compared IL-22 expression and epithelial STAT3 ac-
tivity in colon biopsies of DSS-treated wild-type and Rag1/ 
mice. Interestingly, we found that Rag1/ mice produced 
equal levels of IL-22 and induced epithelial STAT3 activity to 
a similar extent as compared with wild-type mice on day 7   
after colitis induction (Fig. S6). We next isolated lamina pro-
pria cells from DSS-treated wild-type mice and stimulated 
them with LPS, CpG, and lipoteichoic acid. IL-22 was signifi-
cantly induced by all three Toll-like receptor (TLR) ligands, 
therefore supporting a role for innate immune cell–derived 
IL-22 in the regulation of epithelial STAT3 activity (Fig. 4 D). 
To directly identify the source of IL-22 in the lamina propria 
of mice with colitis, we performed immunostaining of colon 
cross sections from animals with established DSS colitis for 
CD11c and IL-22. As demonstrated in Fig. 4 E, CD11c+ cells 
were enriched in the inflamed colon. Moreover, we observed 
a striking colocalization of CD11c and IL-22, suggesting that 
DCs may be an important source for IL-22 in the inflamed 
colon. To further confirm these findings, we sequentially pu-
rified CD11c+, CD4+, and CD11cCD4 cells from the lam-
ina  propria  of  inflamed  colon  tissues  and  cultured  them  for   
24 h. IL-22 was present in both CD11+ and CD4+ cell cultures, 
but  only  little  IL-22  was  produced  by  CD4CD11c  cells   
(Fig. 4 F). Furthermore, when isolated cells were immunostained 
for CD11c and IL-22, we observed colocalization of these 
markers (Fig. 4 F, inset). To investigate whether CD11c+ cell 
expression of IL-22 was limited to colitis, we isolated CD11c+ 
cells from the lamina propria of healthy mice and stimulated 
them with CpG and IL-23, which was recently described as 
an inducer of IL-22 in DCs (Zheng et al., 2008). Again, we 
found that IL-22 expression was markedly induced in lamina 
propria CD11c+ cells (Fig. 4 G), suggesting that DCs stimu-
lated by TLR ligands and IL-23 are an important source of 
IL-22 in acute colitis.
In summary, our observations provide evidence that epi-
thelial STAT3 functions as an important regulator of tissue 
homeostasis in the gut. STAT3 is induced in IECs after in-
duction of colitis or injury, and it regulates several signaling 
pathways that are commonly involved in wound healing. 
Our study furthermore provides evidence that STAT3 acti-
vation during acute colitis is critically dependent on IL-22. 
IL-22 has been described to be produced by activated T cells, 
especially by Th17 cells as well as by DCs and NK cells (Wolk 
and Sabat, 2006; Ouyang et al., 2008). Furthermore, in a 
very recent report, a distinct NK cell population (NKp46+) JEM VOL. 206, July 6, 2009  1471
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Histochemistry. Histopathological analysis was performed on formalin-fixed 
tissue after hematoxylin and eosin (H&E) staining. Epithelial erosion was 
scored as loss of crypts: 1, 0–20%; 2, 20–40%; 3, 40–60%; 4, 60–80%; and 5, 
80–100%. Immunofluorescence of cryosections was performed using the TSA 
Cy3 system (PerkinElmer) and a fluorescence microscope (IX70; Olympus; 
Becker et al., 2004) using primary antibodies directed against pSTAT3, Ki-67 
(Dako), and active caspase-3 (Cell Signaling Technology) and CD11c (BD). 
The nuclei were counterstained with Hoechst 3342 (Invitrogen). Apoptosis 
(TUNEL) was analyzed using the in situ cell death detection kit (Roche).
Statistical analysis. Data were analyzed by the Student’s t test using 
Excel (Microsoft).
Online supplemental material. Fig. S1 shows that STAT3IEC-KO mice 
have no obvious gut phenotype, and Fig. S2 demonstrates changes in the 
expression levels of STAT3 target genes in unchallenged and DSS-treated 
control and STAT3IEC-KO mice. Fig. S3 demonstrates expression of IL-22 
receptor chains in IECs. Figs. S4 and S5 show DSS colitis and in vivo wound 
healing in IL-22/ mice. Fig. S6 demonstrates IL-22/STAT3 signaling in 
RAG1/ mice. Fig. S7 shows IL-22 expression in isolated lamina propria 
CD11c+ cells. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20082683/DC1.
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